JPS5592383A - Novel substituted 55*22imidazolinee22yl** aminopyrimidine*its manufacture and its use as drug - Google Patents

Novel substituted 55*22imidazolinee22yl** aminopyrimidine*its manufacture and its use as drug

Info

Publication number
JPS5592383A
JPS5592383A JP14717779A JP14717779A JPS5592383A JP S5592383 A JPS5592383 A JP S5592383A JP 14717779 A JP14717779 A JP 14717779A JP 14717779 A JP14717779 A JP 14717779A JP S5592383 A JPS5592383 A JP S5592383A
Authority
JP
Japan
Prior art keywords
aminopyrimidine
drug
manufacture
novel substituted
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14717779A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6354714B2 (enExample
Inventor
Sutentsueru Borufugangu
Koonen Eeritsuhi
Furetsuku Borufuganku
Arumaa Ben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of JPS5592383A publication Critical patent/JPS5592383A/ja
Publication of JPS6354714B2 publication Critical patent/JPS6354714B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP14717779A 1978-11-15 1979-11-15 Novel substituted 55*22imidazolinee22yl** aminopyrimidine*its manufacture and its use as drug Granted JPS5592383A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2849537A DE2849537C2 (de) 1978-11-15 1978-11-15 Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
JPS5592383A true JPS5592383A (en) 1980-07-12
JPS6354714B2 JPS6354714B2 (enExample) 1988-10-28

Family

ID=6054732

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14717779A Granted JPS5592383A (en) 1978-11-15 1979-11-15 Novel substituted 55*22imidazolinee22yl** aminopyrimidine*its manufacture and its use as drug

Country Status (4)

Country Link
JP (1) JPS5592383A (enExample)
BE (1) BE880042A (enExample)
DE (1) DE2849537C2 (enExample)
ZA (1) ZA796148B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115833A (ja) * 1984-06-23 1986-01-23 エルテイーエス・ローマン・テラピー―ジユステーメ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツトゲゼルシヤフト 自己付着性膏剤
JPS6115832A (ja) * 1984-06-23 1986-01-23 エルテイーエス・ローマン・テラピー―ジユステーメ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツトゲゼルシヤフト 自己付着性膏剤
JP2023549394A (ja) * 2020-11-12 2023-11-24 スリールセータ エーハゥーエッフ 注意欠陥／多動性障害の新規な治療

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3016767A1 (de) * 1980-04-30 1981-11-05 Beiersdorf Ag, 2000 Hamburg Pyrimidylthioharnstoffe, diese enthaltende arzneimittel und deren verwendung
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel
DE19911371A1 (de) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
WO2004000312A2 (de) 2002-06-19 2003-12-31 Solvay Pharmaceuticals Gmbh Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen
KR20080090546A (ko) * 2006-01-27 2008-10-08 에프. 호프만-라 로슈 아게 Ｃｎｓ 장애 치료용 2-이미다졸의 용도
ES2369113T3 (es) * 2006-06-26 2011-11-25 Chemagis Ltd. Procedimiento mejorado para producir moxonidina.
NZ578260A (en) 2007-02-02 2012-02-24 Hoffmann La Roche Novel 2-aminooxazolines as taar1 ligands for cns disorders
JP5130305B2 (ja) 2007-02-15 2013-01-30 エフ．ホフマン−ラ ロシュ アーゲー Ｔａａｒ１リガンドとしての２−アミノオキサゾリン
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
DE102012215896A1 (de) 2012-09-07 2014-03-13 Wörwag Pharma GmbH & Co.KG Moxonidinsynthese mit Hilfe organischer Basen
ES2608004T3 (es) 2012-12-03 2017-04-05 WÖRWAG PHARMA GmbH & Co. KG Método mediante catálisis por transferencia de fase
EP2765131B1 (en) 2013-02-08 2016-11-23 Arevipharma GmbH Process for the production of Moxonidine
JP6814814B2 (ja) 2016-03-17 2021-01-20 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｔａａｒのアゴニストとしての活性を有する５−エチル−４−メチル−ピラゾール−３−カルボキサミド誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (fr) * 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines
BE503170A (enExample) * 1975-09-02

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115833A (ja) * 1984-06-23 1986-01-23 エルテイーエス・ローマン・テラピー―ジユステーメ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツトゲゼルシヤフト 自己付着性膏剤
JPS6115832A (ja) * 1984-06-23 1986-01-23 エルテイーエス・ローマン・テラピー―ジユステーメ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツトゲゼルシヤフト 自己付着性膏剤
JP2023549394A (ja) * 2020-11-12 2023-11-24 スリールセータ エーハゥーエッフ 注意欠陥／多動性障害の新規な治療

Also Published As

Publication number Publication date
JPS6354714B2 (enExample) 1988-10-28
ZA796148B (en) 1980-11-26
DE2849537A1 (de) 1980-05-22
BE880042A (fr) 1980-05-14
DE2849537C2 (de) 1983-03-17

Similar Documents

Publication Publication Date Title
NZ189378A (en) 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions
JPS54144395A (en) 5*66dimethylpyrrolo*2*33d*pyrimidine*its manufacture and use
NZ190784A (en) Benzofuranyl-piperidines and pharmaceutical compositions
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
JPS5571720A (en) Novel polyether compound*its manufacture and use as medicine
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
JPS5592383A (en) Novel substituted 55*22imidazolinee22yl** aminopyrimidine*its manufacture and its use as drug
JPS5540670A (en) Novel pyrimidone derivative*its manufacture and its medical composition
JPS5625198A (en) Novel niccomycins* their manufacture and their use as insecticide
JPS54122275A (en) Novel substituted diphenyllimidazolyllmethanes* their manufacture and their medical use
JPS55122768A (en) Hydroxypyrimidine derivative*its manufacture and use
JPS54157565A (en) 55nitroimidazole derivative*its manufacture and use
JPS54135779A (en) 1*33dihydroo33*11*22*2*33dihydroo1*44benzoxinee22yl* 22hydroxyethyl*piperidinee44yl**2hhindolee22one novel derivative*its manufacture and use as drug and pharmateutical composition containing said de
IL56878A0 (en) Ketoximimoethers and their use as insecticedes
JPS559074A (en) Compound and drug composition
JPS55149272A (en) Novel 5hhfuranonee2 and 3hhdihydrofuranonee2 derivative* their manufacture and use as medicine
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
JPS54128555A (en) Nnphenylalanine derivative*its manufacture and medicine
JPS54148787A (en) Substituted alkanyllazolyloximeecarbamate* its manufacture and use as insecticide* mitecide and nematodicide
JPS5555127A (en) Substituted 1*111diaminoundecane*its manufacture and its use
JPS54122292A (en) Novel betaalactam*its manufacture and use
NZ189279A (en) Arylaminoimidazolines and pharmaceutical compositions
JPS5572172A (en) Diastereomerr11*44chlorophenoxy**11 *11imidazolyl**3*33dimethyll22butanol*its manufacture and use as drug
NZ189703A (en) N'-glucofuranosid-6-yl-n3-nitroso-ureas and pharmaceutical compositions
JPS5555155A (en) 66methoxyy22acetylnaphthaleneoxime derivative*its manufacture and medical composition